<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34936028</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>22</Day></PubDate></JournalIssue><Title>Cellular and molecular life sciences : CMLS</Title><ISOAbbreviation>Cell Mol Life Sci</ISOAbbreviation></Journal><ArticleTitle>Contingent intramuscular boosting of P2XR7 axis improves motor function in transgenic ALS mice.</ArticleTitle><Pagination><StartPage>7</StartPage><MedlinePgn>7</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00018-021-04070-8</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is a fatal neurodegenerative disorder that leads to progressive degeneration of motor neurons and severe muscle atrophy without effective treatment. Most research on the disease has been focused on studying motor neurons and supporting cells of the central nervous system. Strikingly, the recent observations have suggested that morpho-functional alterations in skeletal muscle precede motor neuron degeneration, bolstering the interest in studying muscle tissue as a potential target for the delivery of therapies. We previously showed that the systemic administration of the P2XR7 agonist, 2'(3')-O-(4-benzoylbenzoyl) adenosine 5-triphosphate (BzATP), enhanced the metabolism and promoted the myogenesis of new fibres in the skeletal muscles of SOD1G93A mice. Here we further corroborated this evidence showing that intramuscular administration of BzATP improved the motor performance of ALS mice by enhancing satellite cells and the muscle pro-regenerative activity of infiltrating macrophages. The preservation of the skeletal muscle retrogradely propagated along with the motor unit, suggesting that backward signalling from the muscle could impinge on motor neuron death. In addition to providing the basis for a suitable adjunct multisystem therapeutic approach in ALS, these data point out that the muscle should be at the centre of ALS research as a target tissue to address novel therapies in combination with those oriented to the CNS.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fabbrizio</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Agostino</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margotta</LastName><ForeName>Cassandra</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mella</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panini</LastName><ForeName>Nicol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratory of Antitumor Pharmacology, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasetto</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Biomarkers, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sammali</LastName><ForeName>Eliana</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Biomarkers, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raggi</LastName><ForeName>Flavia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Azienda Ospedaliera di Padova, Via Giustiniani 2, 35128, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorar&#xf9;</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Azienda Ospedaliera di Padova, Via Giustiniani 2, 35128, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonetto</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Biomarkers, Department of Biochemistry and Molecular Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendotti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nardo</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1803-1484</Identifier><AffiliationInfo><Affiliation>Laboratory of Molecular Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156, Milan, Italy. giovanni.nardo@marionegri.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SG-2018-12366226</GrantID><Agency>Ministero della Salute</Agency><Country/></Grant><Grant><GrantID>PG_8/2020 Macrophals</GrantID><Agency>Fondazione Italiana di Ricerca per la Sclerosi Laterale Amiotrofica</Agency><Country/></Grant><Grant><GrantID>2015-0023</GrantID><Agency>Regione Lombardia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cell Mol Life Sci</MedlineTA><NlmUniqueID>9705402</NlmUniqueID><ISSNLinking>1420-682X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058486">Receptors, Purinergic P2X7</NameOfSubstance></Chemical><Chemical><RegistryNumber>4P5DXU1F8Q</RegistryNumber><NameOfSubstance UI="C033901">3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016764" MajorTopicYN="N">Cell Polarity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003714" MajorTopicYN="N">Denervation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006614" MajorTopicYN="N">Hindlimb</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007273" MajorTopicYN="N">Injections, Intramuscular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000294" MajorTopicYN="N">innervation</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058486" MajorTopicYN="N">Receptors, Purinergic P2X7</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032496" MajorTopicYN="N">Satellite Cells, Skeletal Muscle</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012583" MajorTopicYN="N">Schwann Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012584" MajorTopicYN="N">Sciatic Nerve</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Macrophages</Keyword><Keyword MajorTopicYN="N">Mouse models</Keyword><Keyword MajorTopicYN="N">Myogenesis</Keyword><Keyword MajorTopicYN="N">Satellite cells</Keyword><Keyword MajorTopicYN="N">Skeletal muscle</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>12</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34936028</ArticleId><ArticleId IdType="pmc">PMC8695421</ArticleId><ArticleId IdType="doi">10.1007/s00018-021-04070-8</ArticleId><ArticleId IdType="pii">10.1007/s00018-021-04070-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, et al. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019 doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310&#x2013;323. doi: 10.3109/17482960802566824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N, Nishiyama A, Kato M, et al. Familial amyotrophic lateral sclerosis. Brain Nerve. 2019;71:1169&#x2013;1181. doi: 10.11477/mf.1416201427.</Citation><ArticleIdList><ArticleId IdType="doi">10.11477/mf.1416201427</ArticleId><ArticleId IdType="pubmed">31722303</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z-Y, Zhou Z-R, Che C-H, et al. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540&#x2013;549. doi: 10.1136/jnnp-2016-315018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-315018</ArticleId><ArticleId IdType="pubmed">28057713</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Robberecht W, Van Den Bosch L. Modelling amyotrophic lateral sclerosis: progress and possibilities. DMM Dis Model Mech. 2017;10:537&#x2013;549. doi: 10.1242/dmm.029058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.029058</ArticleId><ArticleId IdType="pmc">PMC5451175</ArticleId><ArticleId IdType="pubmed">28468939</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiot A, Lobsiger CS, Boill&#xe9;e S. New insights on the disease contribution of neuroinflammation in amyotrophic lateral sclerosis. Curr Opin Neurol. 2019;32:764&#x2013;770. doi: 10.1097/WCO.0000000000000729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000729</ArticleId><ArticleId IdType="pubmed">31306211</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR, Simpson EP, Appel SH. Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis. Curr Opin Neurol. 2018;31:635&#x2013;639. doi: 10.1097/WCO.0000000000000599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000599</ArticleId><ArticleId IdType="pubmed">30048339</ArticleId></ArticleIdList></Reference><Reference><Citation>Puentes F, Malaspina A, van Noort JM, Amor S. Non-neuronal cells in ALS: role of glial, immune cells and blood-CNS barriers. Brain Pathol. 2016;26:248&#x2013;257. doi: 10.1111/bpa.12352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12352</ArticleId><ArticleId IdType="pmc">PMC8029111</ArticleId><ArticleId IdType="pubmed">26780491</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouaux C, Panteleeva I, Ren&#xe9; F, et al. Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J Neurosci. 2007 doi: 10.1523/JNEUROSCI.1139-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1139-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672753</ArticleId><ArticleId IdType="pubmed">17522299</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewil M, de la Cruz VF, Van Den Bosch L, Robberecht W. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1G93A-induced motor neuron death. Neurobiol Dis. 2007;26:332&#x2013;341. doi: 10.1016/j.nbd.2006.12.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.12.023</ArticleId><ArticleId IdType="pubmed">17346981</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould TW. Complete dissociation of motor neuron death from motor dysfunction by bax deletion in a mouse model of ALS. J Neurosci. 2006;26:8774&#x2013;8786. doi: 10.1523/JNEUROSCI.2315-06.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2315-06.2006</ArticleId><ArticleId IdType="pmc">PMC6674380</ArticleId><ArticleId IdType="pubmed">16928866</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, Verhaagen J. ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci. 2014 doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, Melamed E, Offen D. The &#x201c;Dying-Back&#x201d; phenomenon of motor neurons in ALS. J Mol Neurosci. 2011;43:470&#x2013;477. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S, Zucca I, Mastropietro A, et al. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study. Exp Neurol. 2011 doi: 10.1016/j.expneurol.2011.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.05.007</ArticleId><ArticleId IdType="pubmed">21620832</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano R, Toivonen JM, Moreno-Mart&#xed;nez L, et al. What skeletal muscle has to say in amyotrophic lateral sclerosis: implications for therapy. Br J Pharmacol. 2021;178:1279&#x2013;1297. doi: 10.1111/bph.15276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15276</ArticleId><ArticleId IdType="pubmed">32986860</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Aucello M, Rizzuto E, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LJ, Wong M. Skeletal muscle-restricted expression of human SOD1 in transgenic mice causes a fatal ALS-like syndrome. Front Neurol. 2020 doi: 10.3389/fneur.2020.592851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.592851</ArticleId><ArticleId IdType="pmc">PMC7767933</ArticleId><ArticleId IdType="pubmed">33381076</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile F, Scarlino S, Falzone YM, et al. The peripheral nervous system in amyotrophic lateral sclerosis: opportunities for translational research. Front Neurosci. 2019 doi: 10.3389/fnins.2019.00601.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00601</ArticleId><ArticleId IdType="pmc">PMC6603245</ArticleId><ArticleId IdType="pubmed">31293369</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza S, Salvatori I, Ferri A, Valle C. Skeletal muscle in ALS: an unappreciated therapeutic opportunity? Cells. 2021;10:525. doi: 10.3390/cells10030525.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030525</ArticleId><ArticleId IdType="pmc">PMC8000428</ArticleId><ArticleId IdType="pubmed">33801336</ArticleId></ArticleIdList></Reference><Reference><Citation>Pikatza-Menoio O, Elicegui A, Bengoetxea X, et al. The skeletal muscle emerges as a new disease target in amyotrophic lateral sclerosis. J Pers Med. 2021;11:671. doi: 10.3390/jpm11070671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11070671</ArticleId><ArticleId IdType="pmc">PMC8307751</ArticleId><ArticleId IdType="pubmed">34357138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Ruiz C, Calzaferri F, Garc&#xed;a AG. P2X7 receptor antagonism as a potential therapy in amyotrophic lateral sclerosis. Front Mol Neurosci. 2020 doi: 10.3389/fnmol.2020.00093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00093</ArticleId><ArticleId IdType="pmc">PMC7303288</ArticleId><ArticleId IdType="pubmed">32595451</ArticleId></ArticleIdList></Reference><Reference><Citation>Volont&#xe9; C, Amadio S, Liguori F, Fabbrizio P. Duality of P2X7 receptor in amyotrophic lateral sclerosis. Front Pharmacol. 2020 doi: 10.3389/fphar.2020.01148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01148</ArticleId><ArticleId IdType="pmc">PMC7394054</ArticleId><ArticleId IdType="pubmed">32792962</ArticleId></ArticleIdList></Reference><Reference><Citation>Monif M, Burnstock G, Williams DA. Microglia: proliferation and activation driven by the P2X7 receptor. Int J Biochem Cell Biol. 2010;42:1753&#x2013;1756. doi: 10.1016/j.biocel.2010.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2010.06.021</ArticleId><ArticleId IdType="pubmed">20599520</ArticleId></ArticleIdList></Reference><Reference><Citation>Massicot F, Hache G, David L, et al. P2X7 cell death receptor activation and mitochondrial impairment in oxaliplatin-induced apoptosis and neuronal injury: cellular mechanisms and in vivo approach. PLoS ONE. 2013;8:e66830. doi: 10.1371/journal.pone.0066830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0066830</ArticleId><ArticleId IdType="pmc">PMC3695015</ArticleId><ArticleId IdType="pubmed">23826152</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobbio L, Sturla L, Fiorese F, et al. P2X7-mediated Increased intracellular calcium causes functional derangement in schwann cells from rats with CMT1A neuropathy. J Biol Chem. 2009;284:23146&#x2013;23158. doi: 10.1074/jbc.M109.027128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.027128</ArticleId><ArticleId IdType="pmc">PMC2755720</ArticleId><ArticleId IdType="pubmed">19546221</ArticleId></ArticleIdList></Reference><Reference><Citation>Lister MF, Sharkey J, Sawatzky DA, et al. The role of the purinergic P2X7 receptor in inflammation. J Inflamm. 2007;4:5. doi: 10.1186/1476-9255-4-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-9255-4-5</ArticleId><ArticleId IdType="pmc">PMC1838907</ArticleId><ArticleId IdType="pubmed">17367517</ArticleId></ArticleIdList></Reference><Reference><Citation>Rissiek B, Haag F, Boyer O, et al. P2X7 on mouse T cells: one channel. Many Functions Front Immunol. 2015 doi: 10.3389/fimmu.2015.00204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00204</ArticleId><ArticleId IdType="pmc">PMC4436801</ArticleId><ArticleId IdType="pubmed">26042119</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbrizio P, Amadio S, Apolloni S, Volont&#xe9; C. P2X7 receptor activation modulates autophagy in SOD1-G93A mouse microglia. Front Cell Neurosci. 2017 doi: 10.3389/fncel.2017.00249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00249</ArticleId><ArticleId IdType="pmc">PMC5566572</ArticleId><ArticleId IdType="pubmed">28871219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Ruiz C, Garc&#xed;a-Magro N, Negredo P, et al. Chronic administration of P2X7 receptor antagonist JNJ-47965567 delays disease onset and progression, and improves motor performance in ALS SOD1G93A female mice. Dis Model Mech. 2020 doi: 10.1242/dmm.045732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.045732</ArticleId><ArticleId IdType="pmc">PMC7648608</ArticleId><ArticleId IdType="pubmed">33174532</ArticleId></ArticleIdList></Reference><Reference><Citation>Apolloni S, Amadio S, Montilli C, et al. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Hum Mol Genet. 2013;22:4102&#x2013;4116. doi: 10.1093/hmg/ddt259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt259</ArticleId><ArticleId IdType="pubmed">23736299</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X, Xu X, Zhu J, et al. Up-regulation of P2X7 receptors mediating proliferation of Schwann cells after sciatic nerve injury. Purinergic Signal. 2015;11:203&#x2013;213. doi: 10.1007/s11302-015-9445-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-015-9445-8</ArticleId><ArticleId IdType="pmc">PMC4425717</ArticleId><ArticleId IdType="pubmed">25682129</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnaghi V, Martin S, Smith P, et al. Peripheral nerve regeneration following injury is altered in mice lacking P2X7 receptor. Eur J Neurosci. 2020 doi: 10.1111/ejn.14995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.14995</ArticleId><ArticleId IdType="pubmed">33012061</ArticleId></ArticleIdList></Reference><Reference><Citation>Panicucci C, Raffaghello L, Bruzzone S, et al. eATP/P2X7R axis: an orchestrated pathway triggering inflammasome activation in muscle diseases. Int J Mol Sci. 2020;21:5963. doi: 10.3390/ijms21175963.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21175963</ArticleId><ArticleId IdType="pmc">PMC7504480</ArticleId><ArticleId IdType="pubmed">32825102</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbrizio P, Apolloni S, Bianchi A, et al. P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Brain Pathol. 2020 doi: 10.1111/bpa.12774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12774</ArticleId><ArticleId IdType="pmc">PMC7065186</ArticleId><ArticleId IdType="pubmed">31376190</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G, Trolese MC, Verderio M, et al. Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice. Mol Neurodegener. 2018;13:42. doi: 10.1186/s13024-018-0271-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0271-7</ArticleId><ArticleId IdType="pmc">PMC6085701</ArticleId><ArticleId IdType="pubmed">30092791</ArticleId></ArticleIdList></Reference><Reference><Citation>Trolese MC, Mariani A, Terao M, et al. CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis. EBioMedicine. 2020;62:103097. doi: 10.1016/j.ebiom.2020.103097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103097</ArticleId><ArticleId IdType="pmc">PMC7670099</ArticleId><ArticleId IdType="pubmed">33161233</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66:265&#x2013;267. doi: 10.1212/01.wnl.0000194316.91908.8a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000194316.91908.8a</ArticleId><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozzetta C, Consalvi S, Saccone V, et al. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol Med. 2013;5:626&#x2013;639. doi: 10.1002/emmm.201202096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201202096</ArticleId><ArticleId IdType="pmc">PMC3628105</ArticleId><ArticleId IdType="pubmed">23505062</ArticleId></ArticleIdList></Reference><Reference><Citation>Amadio S, Parisi C, Piras E, et al. Modulation of P2X7 receptor during inflammation in multiple sclerosis. Front Immunol. 2017 doi: 10.3389/fimmu.2017.01529.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01529</ArticleId><ArticleId IdType="pmc">PMC5694754</ArticleId><ArticleId IdType="pubmed">29187851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeuf-Louchart A, Hardy D, Thorel Q, et al. MuscleJ: a high-content analysis method to study skeletal muscle with a new Fiji tool. Skelet Muscle. 2018;8:25. doi: 10.1186/s13395-018-0171-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-018-0171-0</ArticleId><ArticleId IdType="pmc">PMC6091189</ArticleId><ArticleId IdType="pubmed">30081940</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Bendotti C, Blaugrund E, et al. Guidelines for preclinical animal research in ALS/MND: a consensus meeting. Amyotroph Lateral Scler. 2010;11:38&#x2013;45. doi: 10.3109/17482960903545334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903545334</ArticleId><ArticleId IdType="pubmed">20184514</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Aucello M, Musar&#xf2; A. Muscle atrophy induced by SOD1G93A expression does not involve the activation of caspase in the absence of denervation. Skelet Muscle. 2011;1:3. doi: 10.1186/2044-5040-1-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2044-5040-1-3</ArticleId><ArticleId IdType="pmc">PMC3143901</ArticleId><ArticleId IdType="pubmed">21798081</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Sch&#xfc;ler SC, H&#xfc;ttner SS, et al. Adult stem cells at work: regenerating skeletal muscle. Cell Mol Life Sci. 2019;76:2559&#x2013;2570. doi: 10.1007/s00018-019-03093-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03093-6</ArticleId><ArticleId IdType="pmc">PMC6586695</ArticleId><ArticleId IdType="pubmed">30976839</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet. 2000;57:16&#x2013;25. doi: 10.1034/j.1399-0004.2000.570103.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-0004.2000.570103.x</ArticleId><ArticleId IdType="pubmed">10733231</ArticleId></ArticleIdList></Reference><Reference><Citation>Forcina L, Cosentino M, Musar&#xf2; A. Mechanisms regulating muscle regeneration: insights into the interrelated and time-dependent phases of tissue healing. Cells. 2020;9:1297. doi: 10.3390/cells9051297.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9051297</ArticleId><ArticleId IdType="pmc">PMC7290814</ArticleId><ArticleId IdType="pubmed">32456017</ArticleId></ArticleIdList></Reference><Reference><Citation>Miras-Portugal MT, Gomez-Villafuertes R, Gualix J, et al. Nucleotides in neuroregeneration and neuroprotection. Neuropharmacology. 2016;104:243&#x2013;254. doi: 10.1016/j.neuropharm.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2015.09.002</ArticleId><ArticleId IdType="pubmed">26359530</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnstock G. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Neuropharmacology. 2016;104:4&#x2013;17. doi: 10.1016/j.neuropharm.2015.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2015.05.031</ArticleId><ArticleId IdType="pubmed">26056033</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiley JS, Sluyter R, Gu BJ, et al. The human P2X7 receptor and its role in innate immunity. Tissue Antigens. 2011;78:321&#x2013;332. doi: 10.1111/j.1399-0039.2011.01780.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2011.01780.x</ArticleId><ArticleId IdType="pubmed">21988719</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazaud B. Inflammation and skeletal muscle regeneration: leave it to the macrophages! Trends Immunol. 2020;41:481&#x2013;492. doi: 10.1016/j.it.2020.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.04.006</ArticleId><ArticleId IdType="pubmed">32362490</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidball JG. Regulation of muscle growth and regeneration by the immune system. Nat Rev Immunol. 2017;17:165&#x2013;178. doi: 10.1038/nri.2016.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.150</ArticleId><ArticleId IdType="pmc">PMC5452982</ArticleId><ArticleId IdType="pubmed">28163303</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber&#xe1;-Cremades M, Baroja-Mazo A, Pelegr&#xed;n P. Purinergic signaling during macrophage differentiation results in M2 alternative activated macrophages. J Leukoc Biol. 2016;99:289&#x2013;299. doi: 10.1189/jlb.1A0514-267RR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.1A0514-267RR</ArticleId><ArticleId IdType="pubmed">26382298</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonkin J, Temmerman L, Sampson RD, et al. Monocyte/macrophage-derived IGF-1 orchestrates murine skeletal muscle regeneration and modulates autocrine polarization. Mol Ther. 2015;23:1189&#x2013;1200. doi: 10.1038/mt.2015.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2015.66</ArticleId><ArticleId IdType="pmc">PMC4817788</ArticleId><ArticleId IdType="pubmed">25896247</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Hu P. Skeletal muscle regeneration is modulated by inflammation. J Orthop Transl. 2018;13:25&#x2013;32. doi: 10.1016/j.jot.2018.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jot.2018.01.002</ArticleId><ArticleId IdType="pmc">PMC5892385</ArticleId><ArticleId IdType="pubmed">29662788</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen KR, Mirsky R. The repair Schwann cell and its function in regenerating nerves. J Physiol. 2016;594:3521&#x2013;3531. doi: 10.1113/JP270874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP270874</ArticleId><ArticleId IdType="pmc">PMC4929314</ArticleId><ArticleId IdType="pubmed">26864683</ArticleId></ArticleIdList></Reference><Reference><Citation>Friese A, Kaltschmidt JA, Ladle DR, et al. Gamma and alpha motor neurons distinguished by expression of transcription factor Err3. Proc Natl Acad Sci. 2009;106:13588&#x2013;13593. doi: 10.1073/pnas.0906809106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906809106</ArticleId><ArticleId IdType="pmc">PMC2716387</ArticleId><ArticleId IdType="pubmed">19651609</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G, Trolese MC, Tortarolo M, et al. New insights on the mechanisms of disease course variability in als from mutant SOD1 mouse models. Brain Pathol. 2016;26:237&#x2013;247. doi: 10.1111/bpa.12351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12351</ArticleId><ArticleId IdType="pmc">PMC8029191</ArticleId><ArticleId IdType="pubmed">26780365</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, McGoldrick P, Vance C, et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H, Kleinberger G, Janssens J, et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci. 2010;107:3858&#x2013;3863. doi: 10.1073/pnas.0912417107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0912417107</ArticleId><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Bowser R, Bruijn L, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2013;14:19&#x2013;32. doi: 10.3109/21678421.2013.778554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778554</ArticleId><ArticleId IdType="pmc">PMC4284067</ArticleId><ArticleId IdType="pubmed">23678877</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokic N, Gonzalez de Aguilar J-L, Pradat P-F, et al. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann Neurol. 2005;57:553&#x2013;556. doi: 10.1002/ana.20420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20420</ArticleId><ArticleId IdType="pubmed">15786457</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P-F, Dubourg O, de Tapia M, et al. Muscle gene expression is a marker of amyotrophic lateral sclerosis severity. Neurodegener Dis. 2012;9:38&#x2013;52. doi: 10.1159/000329723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000329723</ArticleId><ArticleId IdType="pubmed">21934272</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinello T, Baldoin MC, Morbiato L, et al. Extracellular ATP signaling during differentiation of C2C12 skeletal muscle cells: role in proliferation. Mol Cell Biochem. 2011;351:183&#x2013;196. doi: 10.1007/s11010-011-0726-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-011-0726-4</ArticleId><ArticleId IdType="pubmed">21308481</ArticleId></ArticleIdList></Reference><Reference><Citation>Araya R, Riquelme MA, Brandan E, S&#xe1;ez JC. The formation of skeletal muscle myotubes requires functional membrane receptors activated by extracellular ATP. Brain Res Rev. 2004;47:174&#x2013;188. doi: 10.1016/j.brainresrev.2004.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2004.06.003</ArticleId><ArticleId IdType="pubmed">15572171</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetman M, Cavanaugh JE, Kimelman D, Xia Z. Role of glycogen synthase kinase-3&#x3b2; in neuronal apoptosis induced by trophic withdrawal. J Neurosci. 2000;20:2567&#x2013;2574. doi: 10.1523/JNEUROSCI.20-07-02567.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02567.2000</ArticleId><ArticleId IdType="pmc">PMC6772233</ArticleId><ArticleId IdType="pubmed">10729337</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega F, P&#xe9;rez-Sen R, Delicado EG, Miras-Portugal MT. P2X7 nucleotide receptor is coupled to GSK-3 inhibition and neuroprotection in cerebellar granule neurons. Neurotox Res. 2009;15:193&#x2013;204. doi: 10.1007/s12640-009-9020-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-009-9020-6</ArticleId><ArticleId IdType="pubmed">19384592</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega F, P&#xe9;rez-Sen R, Delicado EG, Teresa Miras-Portugal M. ERK1/2 activation is involved in the neuroprotective action of P2Y13 and P2X7 receptors against glutamate excitotoxicity in cerebellar granule neurons. Neuropharmacology. 2011;61:1210&#x2013;1221. doi: 10.1016/j.neuropharm.2011.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2011.07.010</ArticleId><ArticleId IdType="pubmed">21798274</ArticleId></ArticleIdList></Reference><Reference><Citation>Le&#xf3;n D, Herv&#xe1;s C, Miras-Portugal MT. P2Y 1 and P2X 7 receptors induce calcium/calmodulin-dependent protein kinase II phosphorylation in cerebellar granule neurons. Eur J Neurosci. 2006;23:2999&#x2013;3013. doi: 10.1111/j.1460-9568.2006.04832.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2006.04832.x</ArticleId><ArticleId IdType="pubmed">16819989</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary JT, Kang Y, Tran M, Feld J. Traumatic injury activates protein kinase B/AKT in cultured astrocytes: role of extracellular ATP and P2 purinergic receptors. J Neurotrauma. 2005;22:491&#x2013;500. doi: 10.1089/neu.2005.22.491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2005.22.491</ArticleId><ArticleId IdType="pubmed">15853465</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Luo Y, Huang Z, et al. Akirin2 regulates proliferation and differentiation of porcine skeletal muscle satellite cells via ERK1/2 and NFATc1 signaling pathways. Sci Rep. 2017;7:45156. doi: 10.1038/srep45156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep45156</ArticleId><ArticleId IdType="pmc">PMC5361102</ArticleId><ArticleId IdType="pubmed">28327665</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones NC, Fedorov YV, Rosenthal RS, Olwin BB. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J Cell Physiol. 2001;186:104&#x2013;115. doi: 10.1002/1097-4652(200101)186:1&lt;104::AID-JCP1015&gt;3.0.CO;2-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-4652(200101)186:1&lt;104::AID-JCP1015&gt;3.0.CO;2-0</ArticleId><ArticleId IdType="pubmed">11147804</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W, Zhu J, Zhuang X, et al. Lipin1 regulates skeletal muscle differentiation through extracellular signal-regulated kinase (ERK) activation and cyclin D complex-regulated cell cycle withdrawal. J Biol Chem. 2015;290:23646&#x2013;23655. doi: 10.1074/jbc.M115.686519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.686519</ArticleId><ArticleId IdType="pmc">PMC4583021</ArticleId><ArticleId IdType="pubmed">26296887</ArticleId></ArticleIdList></Reference><Reference><Citation>Dort J, Fabre P, Molina T, Dumont NA. Macrophages are key regulators of stem cells during skeletal muscle regeneration and diseases. Stem Cells Int. 2019;2019:1&#x2013;20. doi: 10.1155/2019/4761427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4761427</ArticleId><ArticleId IdType="pmc">PMC6664695</ArticleId><ArticleId IdType="pubmed">31396285</ArticleId></ArticleIdList></Reference><Reference><Citation>Bencze M, Negroni E, Vallese D, et al. Proinflammatory macrophages enhance the regenerative capacity of human myoblasts by modifying their kinetics of proliferation and differentiation. Mol Ther. 2012;20:2168&#x2013;2179. doi: 10.1038/mt.2012.189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2012.189</ArticleId><ArticleId IdType="pmc">PMC3498804</ArticleId><ArticleId IdType="pubmed">23070116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigamonti E, Zordan P, Sciorati C, et al. Macrophage plasticity in skeletal muscle repair. Biomed Res Int. 2014;2014:1&#x2013;9. doi: 10.1155/2014/560629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/560629</ArticleId><ArticleId IdType="pmc">PMC4016840</ArticleId><ArticleId IdType="pubmed">24860823</ArticleId></ArticleIdList></Reference><Reference><Citation>Oishi Y, Manabe I. Macrophages in inflammation, repair and regeneration. Int Immunol. 2018;30:511&#x2013;528. doi: 10.1093/intimm/dxy054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxy054</ArticleId><ArticleId IdType="pubmed">30165385</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold L, Henry A, Poron F, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med. 2007;204:1057&#x2013;1069. doi: 10.1084/jem.20070075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20070075</ArticleId><ArticleId IdType="pmc">PMC2118577</ArticleId><ArticleId IdType="pubmed">17485518</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Melton DW, Porter L, et al. Altered macrophage phenotype transition impairs skeletal muscle regeneration. Am J Pathol. 2014;184:1167&#x2013;1184. doi: 10.1016/j.ajpath.2013.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2013.12.020</ArticleId><ArticleId IdType="pmc">PMC3969996</ArticleId><ArticleId IdType="pubmed">24525152</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Liu Y, Zhao L, et al. Macrophage depletion impairs skeletal muscle regeneration: the roles of regulatory factors for muscle regeneration. Cell Biol Int. 2017;41:228&#x2013;238. doi: 10.1002/cbin.10705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.10705</ArticleId><ArticleId IdType="pubmed">27888539</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryer SC, Fantuzzi G, Van Rooijen N, Koh TJ. Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration. J Immunol. 2008;180:1179&#x2013;1188. doi: 10.4049/jimmunol.180.2.1179.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.2.1179</ArticleId><ArticleId IdType="pubmed">18178858</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumont N, Frenette J. Macrophages protect against muscle atrophy and promote muscle recovery in vivo and in vitro. Am J Pathol. 2010;176:2228&#x2013;2235. doi: 10.2353/ajpath.2010.090884.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2010.090884</ArticleId><ArticleId IdType="pmc">PMC2861088</ArticleId><ArticleId IdType="pubmed">20304951</ArticleId></ArticleIdList></Reference><Reference><Citation>Madaro L, Torcinaro A, De Bardi M, et al. Macrophages fine tune satellite cell fate in dystrophic skeletal muscle of mdx mice. PLOS Genet. 2019;15:e1008408. doi: 10.1371/journal.pgen.1008408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1008408</ArticleId><ArticleId IdType="pmc">PMC6821135</ArticleId><ArticleId IdType="pubmed">31626629</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Appel SH. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 2013;8:888&#x2013;899. doi: 10.1007/s11481-013-9489-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-013-9489-x</ArticleId><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;land L-C, Markovinovic A, Jakovac H, et al. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2020 doi: 10.1093/braincomms/fcaa124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa124</ArticleId><ArticleId IdType="pmc">PMC7585698</ArticleId><ArticleId IdType="pubmed">33134918</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo G, Trolese MC, de Vito G, et al. Immune response in peripheral axons delays disease progression in SOD1G93A mice. J Neuroinflammation. 2016;13:261. doi: 10.1186/s12974-016-0732-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0732-2</ArticleId><ArticleId IdType="pmc">PMC5055725</ArticleId><ArticleId IdType="pubmed">27717377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, Phatnani H, Kuligowski M, et al. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc Natl Acad Sci. 2009;106:20960&#x2013;20965. doi: 10.1073/pnas.0911405106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911405106</ArticleId><ArticleId IdType="pmc">PMC2791631</ArticleId><ArticleId IdType="pubmed">19933335</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Lee JD, Woodruff TM, Henderson RD. The peripheral immune system and amyotrophic lateral sclerosis. Front Neurol. 2020 doi: 10.3389/fneur.2020.00279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00279</ArticleId><ArticleId IdType="pmc">PMC7186478</ArticleId><ArticleId IdType="pubmed">32373052</ArticleId></ArticleIdList></Reference><Reference><Citation>Merz J, Nettesheim A, von Garlen S, et al. Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile. Purinergic Signal. 2021 doi: 10.1007/s11302-021-09798-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-021-09798-3</ArticleId><ArticleId IdType="pmc">PMC8410913</ArticleId><ArticleId IdType="pubmed">34282551</ArticleId></ArticleIdList></Reference><Reference><Citation>de Torre-Minguela C, Barber&#xe0;-Cremades M, G&#xf3;mez AI, et al. Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process. Sci Rep. 2016;6:22586. doi: 10.1038/srep22586.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22586</ArticleId><ArticleId IdType="pmc">PMC4776275</ArticleId><ArticleId IdType="pubmed">26935289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino MM, Schneider C, Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci. 2002;22:4825&#x2013;4832. doi: 10.1523/JNEUROSCI.22-12-04825.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-12-04825.2002</ArticleId><ArticleId IdType="pmc">PMC6757755</ArticleId><ArticleId IdType="pubmed">12077179</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo G, Yi J, Ma C, et al. Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. PLoS ONE. 2013;8:e82112. doi: 10.1371/journal.pone.0082112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082112</ArticleId><ArticleId IdType="pmc">PMC3855744</ArticleId><ArticleId IdType="pubmed">24324755</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers JT, King KY, Brett JO, et al. mTORC1 controls the adaptive transition of quiescent stem cells from G0 to GAlert. Nature. 2014;510:393&#x2013;396. doi: 10.1038/nature13255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13255</ArticleId><ArticleId IdType="pmc">PMC4065227</ArticleId><ArticleId IdType="pubmed">24870234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodgers JT, Schroeder MD, Ma C, Rando TA. HGFA is an injury-regulated systemic factor that induces the transition of stem cells into G alert. Cell Rep. 2017;19:479&#x2013;486. doi: 10.1016/j.celrep.2017.03.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.03.066</ArticleId><ArticleId IdType="pmc">PMC5468096</ArticleId><ArticleId IdType="pubmed">28423312</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatsumi R, Sankoda Y, Anderson JE, et al. Possible implication of satellite cells in regenerative motoneuritogenesis: HGF upregulates neural chemorepellent Sema3A during myogenic differentiation. Am J Physiol Physiol. 2009;297:C238&#x2013;C252. doi: 10.1152/ajpcell.00161.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00161.2009</ArticleId><ArticleId IdType="pubmed">19515904</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson JE, Do M-KQ, Daneshvar N, et al. The role of semaphorin3A in myogenic regeneration and the formation of functional neuromuscular junctions on new fibres. Biol Rev. 2017;92:1389&#x2013;1405. doi: 10.1111/brv.12286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12286</ArticleId><ArticleId IdType="pubmed">27296513</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LJ. Neuronal cell death in nervous system development, disease, and injury (review) Int J Mol Med. 2001;7:455&#x2013;478. doi: 10.3892/ijmm.7.5.455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.7.5.455</ArticleId><ArticleId IdType="pubmed">11295106</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Gonzalez de Aguilar J-L, Echaniz-Laguna A, et al. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS ONE. 2009;4:e5390. doi: 10.1371/journal.pone.0005390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005390</ArticleId><ArticleId IdType="pmc">PMC2671839</ArticleId><ArticleId IdType="pubmed">19404401</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Musar&#xf2; A. Understanding ALS: new therapeutic approaches. FEBS J. 2013;280:4315&#x2013;4322. doi: 10.1111/febs.12087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12087</ArticleId><ArticleId IdType="pubmed">23217177</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>